USAMMDA, USAMTEAC teams test field-portable ventilator, prolonged care kit during operational assessment with Fort Liberty-based medical company
U.S. Army Sgt. 1st Class Renee Seymore, left, and Pvt. Aaliyah Kelly treat a combat casualty mannequin during a field exercise and operational assessment, Fort Liberty, North Carolina, Nov. 2, 2023. Seymore is the treatment platoon sergeant and Kelly is a combat medic, both with the 36th Medical Company Area Support (MCAS). During the operational assessment, medical developers with the U.S. Army Medical Materiel Development Activity (USAMMDA) and evaluators from the U.S. Army Medical Test and Evaluation Activity (USAMTEAC) joined the 36th MCAS to test and assess the progress of the Prolonged Care Augmentation Detachment (PCAD) medical equipment set, and the Ventway Sparrow Portable Resuscitator (VSPR). The PCAD and VSPR are development programs designed to enable lifesaving and life prolonging combat casualty care at and near the front lines. USAMMDA and USAMTEAC routinely partner during medical device program development to ensure medical devices meet the high standards of U.S. Army medicine and enable joint force medical providers during both combat operations and training. USAMMDA, the U.S. Department of Defense's lead medical product development activity, develops new drugs, vaccines, devices, and medical support equipment designed to enhance Joint Force readiness and maximize survival of medical casualties on the battlefield. (U.S. Army Photo by T. T. Parish/Released)
